Author

Cemile Elif Özçelik

Bilkent UniversityORCID 0000-0002-3499-4061Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2 Bioengineering· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:drug response / drug discovery· 3 Assay:proteomics· 3 Organism:human· 2 Organism:bacteria (other)· 1 Organism:yeast· 1

Frequent Co-Authors

Urartu Özgür Şafak ŞekeriD· 4 shared Recep Erdem AhaniD· 3 shared Mehmet Seçkin KesiciiD· 2 shared Oğuzhan OğuziD· 2 shared Özge Beğli· 2 shared Salih ÖzçubukçuiD· 2 shared T. Serkan KasırgaiD· 2 shared Ahmet HınçeriD· 1 shared

Activity by Year

2023-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersNeuroscience

Urartu Özgür Şafak ŞekerORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Developing Anti-EGFR/Anti-HER2 Bifunctional Antibody for Solid Tumors by Protein Engineering

Senem Sen, Aslı Semerci, Mélis Karaca, Recep Erdem Ahan, Cemile Elif Özçelik, Elif Duman, Behide Saltepe, Ebru Aras, Eray Ulaş Bozkurt, Hilal Yazıcı, Müge Serhatlı, Urartu Özgür Şafak Şeker

This paper develops a bispecific anti-EGFR/HER2 antibody to enhance antitumor effects by targeting both receptors and improving immune responses.

Biotechnology and Bioengineering · Jul 6, 2026Peer-reviewedBioengineering

Highly Potent Peptide Therapeutics To Prevent Protein Aggregation In Huntington s Disease

Anooshay Khan, Cemile Elif Özçelik, Özge Beğli, Oğuzhan Oğuz, Mehmet Seçkin Kesici, T. Serkan Kasırga, Salih Özçubukçu, Esra Yuca, Urartu Özgür Şafak Şeker

This study identifies three peptides that inhibit mHtt fibril formation in vitro, offering potential therapeutic leads for Huntington's disease.

ACS Medicinal Chemistry Letters · Nov 14, 2023Peer-reviewedNeuroscience

Synergistic Screening of Peptide-Based Biotechnological Drug Candidates for Neurodegenerative Diseases using Yeast Display and Phage Display

Cemile Elif Özçelik, Özge Beğli, Ahmet Hınçer, Recep Erdem Ahan, Mehmet Seçkin Kesici, Oğuzhan Oğuz, T. Serkan Kasırga, Salih Özçubukçu, Urartu Özgür Şafak Şeker

The paper develops a platform combining yeast and phage display to screen peptide therapeutics for neurodegenerative diseases, identifying candidates that inhibit amyloid fibril formation.

ACS Chemical Neuroscience · Aug 28, 2023Peer-reviewedNeuroscience

A Synthetic Protein Secretion System for Living Bacterial Therapeutics

Recep Erdem Ahan, Cemile Elif Özçelik, İrem Niran Çağıl, Urartu Özgür Şafak Şeker

This paper introduces a protein secretion system for gram-negative bacteria to enable targeted protein delivery for therapeutic applications.

bioRxiv · Jun 14, 2023 · PreprintSynthetic Biology